These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3185433)

  • 21. Postoperative respiratory insufficiency.
    Teba L; Omert LA
    Am Fam Physician; 1995 May; 51(6):1473-80. PubMed ID: 7732949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Incorporation of a stimulant of the synthesis and secretion of pulmonary surfactant (ambroxol) in the medical treatment of serous otitis].
    Calero del Castillo JB; Pérez Martínez F; Piqueras Pérez F; Redondo Luciáñez ER
    An Otorrinolaringol Ibero Am; 1988; 15(2):209-18. PubMed ID: 3389499
    [No Abstract]   [Full Text] [Related]  

  • 23. [The antioxidative and inflammation inhibiting properties of ambroxol].
    Winsel K
    Pneumologie; 1992 Sep; 46(9):461-75. PubMed ID: 1438126
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pulmonary surfactant: anti-atelectasis factor].
    Ouellet Y
    Laval Med; 1970 May; 41(5):627-30. PubMed ID: 4928481
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of secretory otitis media with ambroxol].
    Sartoris A
    Acta Otorhinolaryngol Ital; 1987; 7 Suppl 16():51-60. PubMed ID: 3334304
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ambroxol].
    Akkoca Yildiz O
    Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
    [No Abstract]   [Full Text] [Related]  

  • 27. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term treatment of chronic bronchitis with ambroxol].
    Schöpp W
    ZFA (Stuttgart); 1981 Sep; 57(26):1778-86. PubMed ID: 7303838
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of surfactant in pulmonary disorders in full-term infants.
    Sun B
    Curr Opin Pediatr; 1996 Apr; 8(2):113-7. PubMed ID: 8723804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Incorporation of a stimulant of synthesis and secretion of a pulmonary surfactant (ambroxol) into the treatment of otitis serosa].
    Bautista Calero del Castillo J; Pérez Martínez F; Piqueras Pérez F; Redondo Luciáñez ER
    Acta Otorrinolaringol Esp; 1988; 39(1):61-4. PubMed ID: 3272269
    [No Abstract]   [Full Text] [Related]  

  • 31. [Membrane syndrome (respiratory distress syndrome) in newborn infants. Pathogenesis and therapy with special regard to alveolar surface active agent].
    Keuth U
    Fortschr Med; 1973 Jun; 91(16):693-7. PubMed ID: 4740218
    [No Abstract]   [Full Text] [Related]  

  • 32. [Functional examination of the lungs in evaluating the effect of respiratory rehabilitation and mucolytics in cystic fibrosis].
    Zapletal A; Vávrová V; Stefanová J; Horák J; Samánek M
    Cesk Pediatr; 1983 Sep; 38(9):519-24. PubMed ID: 6640752
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of the effects of ambroxol in the surgical preparation of patients with bronchopulmonary disorders. Administration during intermittent positive pressure ventilation].
    Minuto A; Corino T; Ceccopieri M; Bardi F
    Clin Ter; 1984 Dec; 111(6):521-30. PubMed ID: 6396029
    [No Abstract]   [Full Text] [Related]  

  • 34. Ambroxol therapy in simple chronic bronchitis: effects on subjective symptoms and ventilatory function.
    Ericsson CH; Juhász J; Jönsson E; Mossberg B
    Eur J Respir Dis; 1986 Oct; 69(4):248-55. PubMed ID: 3545883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antenatal use of ambroxol (bromhexine metabolite VIII) to prevent hyaline membrane disease: a controlled double-blind study.
    Wauer RR; Schmalisch G; Menzel K; Schröder M; Müller K; Tiller R; Methfessel G; Sitka U; Koepke E; Plath C; Schlegel C; Böttcher M; Köppe I; Fricke U; Severin K; Jacobi R; Schmidt W; Hinkel GK; Nitz I; Kunze D; Reichmann G; Lachmann B; Lampe K; Grauel EL
    Int J Biol Res Pregnancy; 1982; 3(2):84-91. PubMed ID: 7042592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of lasolvan on mucociliary transport in patients with chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA
    Klin Med (Mosk); 1988 Mar; 66(3):45-7. PubMed ID: 3392922
    [No Abstract]   [Full Text] [Related]  

  • 37. [The mechanism of respiratory insufficiency in surgery and traumatology].
    Molcho M
    Harefuah; 1973 Jan; 84(2):97-9. PubMed ID: 4739984
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prenatal prevention of infant respiratory distress syndrome. 2nd part: clinical applications and indications].
    Lenclen R; Paupe A; Philippe HJ; Olivier-Martin M; Nisand I
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):294-309. PubMed ID: 7622778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New concepts in the therapy of mucostasis].
    von Seefeld H; Weiss JM; Rensch H
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():896-900. PubMed ID: 6689074
    [No Abstract]   [Full Text] [Related]  

  • 40. Randomized double blind trial of Ambroxol for the treatment of respiratory distress syndrome.
    Wauer RR; Schmalisch G; Böhme B; Arand J; Lehmann D
    Eur J Pediatr; 1992 May; 151(5):357-63. PubMed ID: 1396891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.